NPPA extends price cap on knee implants by a year
India's drug pricing regulator has extended the price cap on knee implants. This decision will continue to benefit patients by keeping costs down. The National Pharmaceutical Pricing Authority decided not to revise the prices for another year. Manufacturers had argued for a price increase, citing research and development needs.
13 C